Target intelligence / Profile preview

RAS protein activator like 3 (RASAL3)

Target
RASAL3
Molecular classification
Enzyme, GTPase-activating protein (RasGAP family), Signaling molecule
01

Overview

RAS protein activator like 3 (RASAL3) is an enzyme in the Ras GTPase-activating protein family that negatively regulates the Ras signaling pathway by accelerating the hydrolysis of GTP bound to Ras, inactivating Ras proteins. It contains several domains, including pleckstrin homology (PH), C2, and RasGAP domains, and localizes near or at the plasma membrane. RASAL3 is important in immune cell (natural killer T cell) expansion and function, and reduced expression is linked to increased Ras activity. Dysregulation of RASAL3 is implicated in certain proliferative and developmental disorders, including epiphyseal dysplasia and various cancers[1][3].

Other names
RASAL3
02

Mechanism of action

Drugs inhibiting or modifying RasGAPs would *modulate Ras signaling* pathways, generally by affecting the hydrolysis of GTP on Ras and thus Ras activity

03

Biological functions

Signal transductionNegative regulation of Ras signalingRegulation of MAPK/ERK pathwayRegulation of natural killer T cell expansion and function
04

Disease associations

CancerEpiphyseal dysplasiaImmune regulationOther
05

Safety considerations

Targeting Ras or its regulators can potentially affect normal cell proliferation, immune function, and cell survival, so there may be risks of unwanted activation or inhibition leading to cancer or immune dysregulation

Beyond the preview

Go deeper on RAS protein activator like 3 (RASAL3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RAS protein activator like 3 (RASAL3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call